|
Exsular Financial Group Inc (FDMG) |
|
|
|
Exsular Financial Group Inc Income Statement Quarterly
FDMG
Select the Financial Report: |
Period: |
|
|
INCOME STATEMENT (Quarterly GAAP In millions $) |
(Sep 30 2022) Q1 2023 |
(Mar 31 2022) Q1 2022 |
(Dec 31 2021) Q4 2021 |
(Sep 30 2021) Q3 2021 |
(Jun 30 2021) Q2 2021 |
Total Revenues |
- |
- |
|
- |
- |
Total Revenue |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Cost of Goods Sold |
- |
- |
- |
- |
- |
Gross
Profit |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Selling, Administration, Marketing |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Depriciation & Amortization |
- |
- |
- |
- |
- |
Research & development |
- |
- |
- |
- |
- |
Restructuring, Accretion & impairment charges |
- |
- |
- |
- |
- |
Other operatinig exp. /-income |
- |
0.00 |
- |
- |
- |
Unusual Expense /-Income |
- |
- |
- |
- |
- |
Fees and Commission |
0.01 |
0.01 |
0.00 |
0.00 |
0.00 |
Total operating costs including COS |
0.01 |
0.01 |
0.01 |
0.01 |
0.00 |
Operating income/-loss
|
-0.01 |
-0.01 |
-0.01 |
-0.01 |
0.00 |
Other Deductions / - Income |
Interest expense |
- |
- |
- |
- |
- |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
- |
- |
- |
- |
- |
Loss/ -Gain on Investment |
- |
- |
- |
- |
- |
Foreign Currency Transaction (Gain) Loss |
- |
- |
- |
- |
- |
Allowances, Health Care Trust Fund And Other |
- |
- |
- |
- |
- |
Unexpected (Gain) Loss |
- |
- |
- |
- |
- |
Other loss/ -income |
- |
- |
0.00 |
0.00 |
- |
Total costs & expenses |
0.01 |
0.01 |
0.01 |
0.01 |
0.00 |
Income /-loss before income taxes |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
0.00 |
Income taxes expenses/-benefit |
- |
- |
- |
- |
- |
Income after income taxes |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
0.00 |
Net income/-loss
of other equity |
- |
- |
- |
- |
- |
Income/-loss
from cont. Ops. |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
0.00 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
0.00 |
Non-controlling interests |
- |
- |
- |
- |
- |
Preferred dividends |
- |
- |
- |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
0.00 |
EBIT |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
0.00 |
EBITD |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
0.00 |
EBITDA |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
0.00 |
Per
Share (GAAP Quarterly, in $) |
(Sep 30 2022) Q1 2023 |
(Mar 31 2022) Q1 2022 |
(Dec 31 2021) Q4 2021 |
(Sep 30 2021) Q3 2021 |
(Jun 30 2021) Q2 2021 |
Basic EPS (excl. extra
items) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Extraordinary items |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Basic Net EPS |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Basic shares outstanding (Mill.
of Units) |
5.52 |
5.52 |
5.52 |
5.52 |
5.52 |
EPS other shares |
- |
- |
- |
- |
- |
Diluted Net EPS |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Diluted average shares (Mill.
of Units) |
5.52 |
5.52 |
5.52 |
5.52 |
5.52 |
Dividend per share |
- |
- |
- |
- |
- |
|
|